Ali Nebioğlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Nebioğlu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Mert Başaranoğlu
Mersin Universitesi
8 shared publications - Murat Bozlu
Department of Urology, Mersin University Faculty of Medicine, Mersin, Turkey
8 shared publications - Erdem Akbay
Department of Urology, Faculty of Medicine, Mersin University, Mersin, Turkey
7 shared publications - Ahmet Turhan
Mersin Universitesi
4 shared publications - Hasan Erdal Doruk
Department of Urology, Mersin University Faculty of Medicine, Mersin, Turkey
4 shared publications - Yasemin Yuyucu Karabulut
Department of Pathology, Mersin University School of Medicine, Mersin, Türkiye
4 shared publications
Latest Publications
- Open Access
Early Dynamic 18F-FDG PET/CT SUVmax and Its Association with Pathological Stage and Tumor Grade in Bladder Cancer: A Prospective Exploratory Study
Background and Objectives: Accurate preoperative staging and grade assessment are crucial for optimal treatment selection in bladder cancer. This prospective study evaluated multi-timepoint Fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) imaging for predicting pathological stage and tumor grade. Materials and Methods: Seventy-two patients with bladder carcinoma underwent 18F-FDG PET/CT including early dynamic (0–2, 2–4, 8–10 min), standard (60 min), and late (~120 min) imaging following a standardized furosemide hydration protocol. Maximum standardized uptake values (SUVmax) were correlated with histopathological findings. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis with Youden index for optimal cut-offs. Results: The cohort comprised 72 patients (84.7% male, mean age 64.8 ± 10.7 years) with pathological stages Ta (36.1%), CIS (15.3%), T1 (31.9%), and T2 (16.7%). High-grade tumors demonstrated significantly higher SUVmax at early dynamic imaging (0–2 min: 1.50 vs. 1.00, p = 0.028) and late imaging (11.40 vs. 9.50, p = 0.045) compared to low-grade tumors. Early dynamic imaging at 0–2 min achieved the highest, although modest, diagnostic performance for high-grade prediction (area under the curve (AUC) = 0.652) and muscle-invasive disease prediction (AUC = 0.669), with optimal cut-offs of SUVmax = 1.40 and 1.80, respectively. Early dynamic SUVmax correlated significantly with tumor grade (ρ = 0.261, p = 0.027) and tumor size (ρ = 0.424, p < 0.001). The negative predictive value for muscle-invasive disease was 90.4%, but sensitivity was only 58.3%. Conclusions: Early dynamic 18F-FDG PET/CT imaging at 0–2 min showed the highest, although modest, diagnostic performance among the evaluated time points for predicting tumor grade and muscle invasion. The identified SUVmax cut-offs are exploratory and require external validation in larger multicenter studies before clinical use. Trial registration: Not registered.
Open AccessEarly Dynamic 18F-FDG PET/CT SUVmax and Its Association with Pathological Stage and Tumor Grade in Bladder Cancer: A Prospective Exploratory Study
Background and Objectives: Accurate preoperative staging and grade assessment are crucial for optimal treatment selection in bladder cancer. This prospective study evaluated multi-timepoint Fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) imaging for predicting pathological stage and tumor grade. Materials and Methods: Seventy-two patients with bladder carcinoma underwent 18F-FDG PET/CT including early dynamic (0–2, 2–4, 8–10 min), standard (60 min), and late (~120 min) imaging following a standardized furosemide hydration protocol. Maximum standardized uptake values (SUVmax) were correlated with histopathological findings. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis with Youden index for optimal cut-offs. Results: The cohort comprised 72 patients (84.7% male, mean age 64.8 ± 10.7 years) with pathological stages Ta (36.1%), CIS (15.3%), T1 (31.9%), and T2 (16.7%). High-grade tumors demonstrated significantly higher SUVmax at early dynamic imaging (0–2 min: 1.50 vs. 1.00, p = 0.028) and late imaging (11.40 vs. 9.50, p = 0.045) compared to low-grade tumors. Early dynamic imaging at 0–2 min achieved the highest, although modest, diagnostic performance for high-grade prediction (area under the curve (AUC) = 0.652) and muscle-invasive disease prediction (AUC = 0.669), with optimal cut-offs of SUVmax = 1.40 and 1.80, respectively. Early dynamic SUVmax correlated significantly with tumor grade (ρ = 0.261, p = 0.027) and tumor size (ρ = 0.424, p < 0.001). The negative predictive value for muscle-invasive disease was 90.4%, but sensitivity was only 58.3%. Conclusions: Early dynamic 18F-FDG PET/CT imaging at 0–2 min showed the highest, although modest, diagnostic performance among the evaluated time points for predicting tumor grade and muscle invasion. The identified SUVmax cut-offs are exploratory and require external validation in larger multicenter studies before clinical use. Trial registration: Not registered.
- Open Access
- 19 September 2026
- Published by Springer Nature in BMC Urology
Association of metformin exposure with oncological outcomes in BCG-treated non-muscle-invasive bladder cancer: a three-arm retrospective cohort study
- 19 September 2026
- Published by Springer Nature in BMC Urology
Open AccessAssociation of metformin exposure with oncological outcomes in BCG-treated non-muscle-invasive bladder cancer: a three-arm retrospective cohort study
- Open Access
- 17 March 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 247
Procedural factors outweigh anatomical morphometry in predicting postoperative pain following retrograde intrarenal surgery
Purpose: Postoperative pain affects 23–45% of RIRS patients, but predictive factors remain unclear. This study evaluated whether anatomical morphometric assessment predicts postoperative pain when controlling for procedural variables in patients with normal upper tract anatomy, and identified which factors most significantly influence pain after RIRS. Methods: This prospective single-center study included 420 consecutive patients undergoing RIRS (September 2024–May 2025). After exclusions, 320 patients completed three-week follow-up. Forty-five anatomical parameters and procedural variables (intrarenal pressure, laser parameters, access sheath use, complications) were recorded. Pain was assessed using VAS (seven timepoints) and Turkish USSQ. Analysis employed multiple comparison corrections, hierarchical regression, propensity score matching, and cross-validation. Results: Among 320 patients (67.8% male; mean age 51.6 ± 13.2 years), procedural factors primarily predicted postoperative pain. Intrarenal pressure ( r = 0.448), complications ( r = 0.418), and laser energy ( r = 0.382) showed significant correlations with pain, accounting for most variance (R²=0.424). Anatomical parameters provided negligible predictive value (R²=-0.018), with no significant correlations after multiple testing correction. DJ stent pain was context-dependent, higher in high-pressure procedures but resolving rapidly post-removal in 89% of cases. Conclusion: Modifiable procedural factors—intrarenal pressure, complications, and laser energy—are the main determinants of postoperative pain following RIRS in patients with normal anatomy, while anatomical measurements lack predictive value. Optimizing intraoperative practices offers greater clinical benefit than preoperative morphometric assessment. These findings support deprioritizing resource-intensive anatomical profiling for pain prediction in RIRS. Preoperative anatomical profiling should not be routinely performed for pain prediction, as procedural optimization represents modifiable targets with greater impact on patient outcomes.
- 17 March 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 247
Open AccessProcedural factors outweigh anatomical morphometry in predicting postoperative pain following retrograde intrarenal surgery
Purpose: Postoperative pain affects 23–45% of RIRS patients, but predictive factors remain unclear. This study evaluated whether anatomical morphometric assessment predicts postoperative pain when controlling for procedural variables in patients with normal upper tract anatomy, and identified which factors most significantly influence pain after RIRS. Methods: This prospective single-center study included 420 consecutive patients undergoing RIRS (September 2024–May 2025). After exclusions, 320 patients completed three-week follow-up. Forty-five anatomical parameters and procedural variables (intrarenal pressure, laser parameters, access sheath use, complications) were recorded. Pain was assessed using VAS (seven timepoints) and Turkish USSQ. Analysis employed multiple comparison corrections, hierarchical regression, propensity score matching, and cross-validation. Results: Among 320 patients (67.8% male; mean age 51.6 ± 13.2 years), procedural factors primarily predicted postoperative pain. Intrarenal pressure ( r = 0.448), complications ( r = 0.418), and laser energy ( r = 0.382) showed significant correlations with pain, accounting for most variance (R²=0.424). Anatomical parameters provided negligible predictive value (R²=-0.018), with no significant correlations after multiple testing correction. DJ stent pain was context-dependent, higher in high-pressure procedures but resolving rapidly post-removal in 89% of cases. Conclusion: Modifiable procedural factors—intrarenal pressure, complications, and laser energy—are the main determinants of postoperative pain following RIRS in patients with normal anatomy, while anatomical measurements lack predictive value. Optimizing intraoperative practices offers greater clinical benefit than preoperative morphometric assessment. These findings support deprioritizing resource-intensive anatomical profiling for pain prediction in RIRS. Preoperative anatomical profiling should not be routinely performed for pain prediction, as procedural optimization represents modifiable targets with greater impact on patient outcomes.
- Open Access
- 28 January 2026
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Effects of dutasteride with Bacillus Calmette-Guérin therapy on recurrence, progression, metastasis, and survival in non-muscle invasive bladder cancer: a retrospective single-center study
To evaluate the impact of dutasteride, a 5-alpha reductase inhibitor, used alongside intravesical Bacillus Calmette-Guérin therapy on recurrence, prog
- 28 January 2026
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Open AccessEffects of dutasteride with Bacillus Calmette-Guérin therapy on recurrence, progression, metastasis, and survival in non-muscle invasive bladder cancer: a retrospective single-center study
To evaluate the impact of dutasteride, a 5-alpha reductase inhibitor, used alongside intravesical Bacillus Calmette-Guérin therapy on recurrence, prog
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (3) , e20251628
Elevated serum Raftlin levels in non-muscle invasive bladder cancer: diagnostic implications and rs690037 genotype analysis
SUMMARY OBJECTIVE: Non-muscle invasive bladder cancer is a common urological malignancy characterized by high recurrence and progression rates. There is a critical need for non-invasive biomarkers to support early detection and disease monitoring. Raftlin, a lipid raft-associated scaffold protein involved in immune regulation and signal transduction, has recently gained attention in cancer biology. The aim of this study was to investigate serum Raftlin levels and the rs690037 polymorphism of the Raftlin gene in non-muscle invasive bladder cancer patients. METHODS: A case-control study was conducted, including 30 patients diagnosed with non-muscle invasive bladder cancer and 50 healthy controls. Serum Raftlin levels were measured using enzyme-linked immunosorbent assay, and the rs690037 polymorphism was analyzed using real-time polymerase chain reaction. Gender-stratified analysis and receiver operating characteristic curve analysis were performed. Clinical and pathological characteristics including tumor stage, grade, and European Organisation for Research and Treatment of Cancer risk groups, were analyzed. RESULTS: Serum Raftlin levels were significantly elevated in non-muscle invasive bladder cancer patients compared to healthy controls (p<0.001). Gender-stratified analysis confirmed this association was independent of gender (males: p<0.001; females: p<0.001). Receiver operating characteristic curve analysis demonstrated an area under the curve of 0.987 (95%CI 0.966–1.000), with an optimal cut-off of 5.28 ng/mL providing 96.7% sensitivity and 98.0% specificity. Trends toward higher Raftlin levels were observed in more aggressive disease features. No significant association was found between the rs690037 polymorphism and disease presence. CONCLUSION: This pilot study suggests that serum Raftlin levels are significantly elevated in non-muscle invasive bladder cancer and show high discriminatory ability. While preliminary findings suggest potential as a non-invasive biomarker, validation in larger, independent cohorts is required before clinical implementation.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (3) , e20251628
Open AccessElevated serum Raftlin levels in non-muscle invasive bladder cancer: diagnostic implications and rs690037 genotype analysis
SUMMARY OBJECTIVE: Non-muscle invasive bladder cancer is a common urological malignancy characterized by high recurrence and progression rates. There is a critical need for non-invasive biomarkers to support early detection and disease monitoring. Raftlin, a lipid raft-associated scaffold protein involved in immune regulation and signal transduction, has recently gained attention in cancer biology. The aim of this study was to investigate serum Raftlin levels and the rs690037 polymorphism of the Raftlin gene in non-muscle invasive bladder cancer patients. METHODS: A case-control study was conducted, including 30 patients diagnosed with non-muscle invasive bladder cancer and 50 healthy controls. Serum Raftlin levels were measured using enzyme-linked immunosorbent assay, and the rs690037 polymorphism was analyzed using real-time polymerase chain reaction. Gender-stratified analysis and receiver operating characteristic curve analysis were performed. Clinical and pathological characteristics including tumor stage, grade, and European Organisation for Research and Treatment of Cancer risk groups, were analyzed. RESULTS: Serum Raftlin levels were significantly elevated in non-muscle invasive bladder cancer patients compared to healthy controls (p<0.001). Gender-stratified analysis confirmed this association was independent of gender (males: p<0.001; females: p<0.001). Receiver operating characteristic curve analysis demonstrated an area under the curve of 0.987 (95%CI 0.966–1.000), with an optimal cut-off of 5.28 ng/mL providing 96.7% sensitivity and 98.0% specificity. Trends toward higher Raftlin levels were observed in more aggressive disease features. No significant association was found between the rs690037 polymorphism and disease presence. CONCLUSION: This pilot study suggests that serum Raftlin levels are significantly elevated in non-muscle invasive bladder cancer and show high discriminatory ability. While preliminary findings suggest potential as a non-invasive biomarker, validation in larger, independent cohorts is required before clinical implementation.
- Open Access
Prognostic Significance of Hemogram Parameters in Non-Muscle Invasive Bladder Cancer: A Comprehensive Retrospective Analysis
Background and Objectives: To evaluate the prognostic significance of preoperative complete blood count parameters in patients with non–muscle-invasive bladder cancer (NMIBC), to determine optimal cutoff values, and to explore their potential integration into existing risk stratification systems. Materials and Methods: In this retrospective cohort study, 551 patients with NMIBC treated between January 2007 and December 2024 were analyzed. Complete blood count parameters obtained within 30 days prior to transurethral resection were collected. The primary endpoints were disease recurrence and progression. Statistical analyses included the Mann–Whitney U test, Kaplan–Meier survival analysis, Cox proportional hazards regression, and receiver operating characteristic (ROC) curve analysis. Results: Complete data were available for 548 patients (mean age 66.3 ± 11.3 years, 70.3% male). Disease recurrence occurred in 203 patients (37.0%) and progression in 60 patients (10.9%). Compared with the non-recurrence group, patients with recurrence had lower hemoglobin (11.8 ± 2.3 vs. 13.2 ± 2.4 g/dL, p < 0.001), higher lymphocyte counts (2.4 ± 3.3 vs. 2.1 ± 2.9 ×103/µL, p = 0.025), and lower neutrophil counts (5.3 ± 3.0 vs. 6.1 ± 3.4 × 103/µL, p < 0.001). In multivariable analysis, hemoglobin (HR 0.75, 95% CI 0.68–0.83, p < 0.001), age (HR 1.02, 95% CI 1.00–1.03, p = 0.023), and carcinoma in situ (HR 1.69, 95% CI 1.13–2.53, p = 0.011) were independent predictors of recurrence. Hemoglobin yielded the highest AUC for predicting recurrence (0.692). Conclusions: Routinely available hematologic indices—particularly hemoglobin concentration—exhibit independent prognostic value in patients with NMIBC. Incorporating these parameters into established risk stratification models may enhance personalized treatment strategies.
Open AccessPrognostic Significance of Hemogram Parameters in Non-Muscle Invasive Bladder Cancer: A Comprehensive Retrospective Analysis
Background and Objectives: To evaluate the prognostic significance of preoperative complete blood count parameters in patients with non–muscle-invasive bladder cancer (NMIBC), to determine optimal cutoff values, and to explore their potential integration into existing risk stratification systems. Materials and Methods: In this retrospective cohort study, 551 patients with NMIBC treated between January 2007 and December 2024 were analyzed. Complete blood count parameters obtained within 30 days prior to transurethral resection were collected. The primary endpoints were disease recurrence and progression. Statistical analyses included the Mann–Whitney U test, Kaplan–Meier survival analysis, Cox proportional hazards regression, and receiver operating characteristic (ROC) curve analysis. Results: Complete data were available for 548 patients (mean age 66.3 ± 11.3 years, 70.3% male). Disease recurrence occurred in 203 patients (37.0%) and progression in 60 patients (10.9%). Compared with the non-recurrence group, patients with recurrence had lower hemoglobin (11.8 ± 2.3 vs. 13.2 ± 2.4 g/dL, p < 0.001), higher lymphocyte counts (2.4 ± 3.3 vs. 2.1 ± 2.9 ×103/µL, p = 0.025), and lower neutrophil counts (5.3 ± 3.0 vs. 6.1 ± 3.4 × 103/µL, p < 0.001). In multivariable analysis, hemoglobin (HR 0.75, 95% CI 0.68–0.83, p < 0.001), age (HR 1.02, 95% CI 1.00–1.03, p = 0.023), and carcinoma in situ (HR 1.69, 95% CI 1.13–2.53, p = 0.011) were independent predictors of recurrence. Hemoglobin yielded the highest AUC for predicting recurrence (0.692). Conclusions: Routinely available hematologic indices—particularly hemoglobin concentration—exhibit independent prognostic value in patients with NMIBC. Incorporating these parameters into established risk stratification models may enhance personalized treatment strategies.
- Open Access
- 29 June 2025
- Published by Pera Yayıncılık Hizmetleri in The New Journal of Urology
- Vol. 20 (2) , 113
Hundreds of Ileal Condylitis Stones
One of the long-term complications of urinary diversion, urolithiasis, is influenced by factors such as bacterial colonization, urinary stasis, mucus, and anatomical abnormalities. Stones are typically observed in the upper urinary tract, and they are rarely seen in the ileal conduit. Although endoscopic surgery can be used for the treatment of stones in the ileal conduit, it is predominantly treated with open surgery. We report a 28-year-old male patient with 282 urinary stones, the largest of which measures 8 cm, found in the ileal conduit. The case is evaluated in terms of treatment and surgical approaches. Keywords: ileal conduit, lithotripsy, urolithiasis, urinary diversion
- 29 June 2025
- Published by Pera Yayıncılık Hizmetleri in The New Journal of Urology
- Vol. 20 (2) , 113
Open AccessHundreds of Ileal Condylitis Stones
One of the long-term complications of urinary diversion, urolithiasis, is influenced by factors such as bacterial colonization, urinary stasis, mucus, and anatomical abnormalities. Stones are typically observed in the upper urinary tract, and they are rarely seen in the ileal conduit. Although endoscopic surgery can be used for the treatment of stones in the ileal conduit, it is predominantly treated with open surgery. We report a 28-year-old male patient with 282 urinary stones, the largest of which measures 8 cm, found in the ileal conduit. The case is evaluated in terms of treatment and surgical approaches. Keywords: ileal conduit, lithotripsy, urolithiasis, urinary diversion
- Open Access
- 1 June 2025
- Published by SAGE Publications in Bladder Cancer
- Vol. 11 (3)
Impact of lymphovascular invasion and histological variants on BCG-treated high-grade NMIBC prognosis
Purpose: This study aimed to evaluate the impact of lymphovascular invasion (LVI) and histologic subtypes on prognosis following Bacillus Calmette-Guérin (BCG) therapy in high-grade non-muscle invasive bladder cancer (NMIBC). Methods: We retrospectively analyzed 245 patients who underwent transurethral resection of bladder tumor (TURBT) for high-grade Ta, T1, or carcinoma in situ (CIS) and received BCG therapy between January 2010 and December 2020. Effects of LVI and histologic subtypes on recurrence-free survival (RFS) and progression-free survival (PFS) were assessed using Kaplan-Meier and Cox regression analyses. Results: At median follow-up of 48.5 months, LVI was detected in 25.7% of patients and histologic subtypes in 36.3%. During follow-up, disease recurrence occurred in 98 patients (40.0%) and progression in 45 patients (18.4%). In multivariate analysis, LVI (HR: 2.28, 95% CI: 1.68–3.10, p < 0.001) and histologic subtypes ≥1% (HR: 1.95, 95% CI: 1.45–2.62, p < 0.001) were independent risk factors for recurrence. Similarly, LVI (HR: 2.85, 95% CI: 1.98–4.11, p < 0.001) and histologic subtypes ≥1% (HR: 2.34, 95% CI: 1.67–3.28, p < 0.001) were independent risk factors for progression. Patients with concurrent LVI and histologic subtypes demonstrated highest risk of progression (HR: 4.15, 95% CI: 2.85–6.05, p < 0.001) with 5-year PFS rate of 45.2%. Conclusion: In high-grade NMIBC patients receiving BCG therapy, LVI and histologic subtypes are strong independent risk factors for disease recurrence and progression. Patients with both factors have highest risk and may require more aggressive treatment strategies including consideration of early radical cystectomy. These findings support the importance of detailed pathological assessment in treatment selection for BCG-treated NMIBC patients.
- 1 June 2025
- Published by SAGE Publications in Bladder Cancer
- Vol. 11 (3)
Open AccessImpact of lymphovascular invasion and histological variants on BCG-treated high-grade NMIBC prognosis
Purpose: This study aimed to evaluate the impact of lymphovascular invasion (LVI) and histologic subtypes on prognosis following Bacillus Calmette-Guérin (BCG) therapy in high-grade non-muscle invasive bladder cancer (NMIBC). Methods: We retrospectively analyzed 245 patients who underwent transurethral resection of bladder tumor (TURBT) for high-grade Ta, T1, or carcinoma in situ (CIS) and received BCG therapy between January 2010 and December 2020. Effects of LVI and histologic subtypes on recurrence-free survival (RFS) and progression-free survival (PFS) were assessed using Kaplan-Meier and Cox regression analyses. Results: At median follow-up of 48.5 months, LVI was detected in 25.7% of patients and histologic subtypes in 36.3%. During follow-up, disease recurrence occurred in 98 patients (40.0%) and progression in 45 patients (18.4%). In multivariate analysis, LVI (HR: 2.28, 95% CI: 1.68–3.10, p < 0.001) and histologic subtypes ≥1% (HR: 1.95, 95% CI: 1.45–2.62, p < 0.001) were independent risk factors for recurrence. Similarly, LVI (HR: 2.85, 95% CI: 1.98–4.11, p < 0.001) and histologic subtypes ≥1% (HR: 2.34, 95% CI: 1.67–3.28, p < 0.001) were independent risk factors for progression. Patients with concurrent LVI and histologic subtypes demonstrated highest risk of progression (HR: 4.15, 95% CI: 2.85–6.05, p < 0.001) with 5-year PFS rate of 45.2%. Conclusion: In high-grade NMIBC patients receiving BCG therapy, LVI and histologic subtypes are strong independent risk factors for disease recurrence and progression. Patients with both factors have highest risk and may require more aggressive treatment strategies including consideration of early radical cystectomy. These findings support the importance of detailed pathological assessment in treatment selection for BCG-treated NMIBC patients.
- Open Access
- 21 May 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 38 (1) , 44-50
Impact of sleep quality and chronotype on self-reported erectile function in young adults presenting with erectile complaints: a prospective observational study
Erectile complaints are prevalent among young adults, with various factors potentially affecting sexual function and quality of life. This study investigates the impact of sleep quality and chronotype on erectile function in young adults who present with self-reported erectile difficulties. In this prospective study, 249 men with ED were included, assessed from January 2023 to July 2024. Sociodemographic and clinical data were collected for all participants, including age, body mass index (BMI), comorbid diseases, and hormonal parameters. All patients completed the following questionnaires: International Index of Erectile Function (IIEF-5), Pittsburgh Sleep Quality Index (PSQI), Morningness-Eveningness Questionnaire (MEQ), Depression Anxiety Stress Scales-42 (DASS-42), and General Health Questionnaire-28 (GHQ-28). Statistical analyses, including Spearman’s correlation and Kruskal-Wallis tests, evaluated the relationships between sleep quality, chronotype, and ED. The average age was 31.03 ± 8.06 years. Significant correlations were found: Poor sleep quality was linked to lower erectile function (r = −0.379, p < 0.001), while morning chronotype correlated with better erectile function (r = 0.424, p < 0.001). Regression analysis confirmed these as significant predictors of ED (R 2 = 0.200, p < 0.001). Sleep quality and chronotype are crucial factors in ED management, suggesting targeted interventions could be beneficial.
- 21 May 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 38 (1) , 44-50
Open AccessImpact of sleep quality and chronotype on self-reported erectile function in young adults presenting with erectile complaints: a prospective observational study
Erectile complaints are prevalent among young adults, with various factors potentially affecting sexual function and quality of life. This study investigates the impact of sleep quality and chronotype on erectile function in young adults who present with self-reported erectile difficulties. In this prospective study, 249 men with ED were included, assessed from January 2023 to July 2024. Sociodemographic and clinical data were collected for all participants, including age, body mass index (BMI), comorbid diseases, and hormonal parameters. All patients completed the following questionnaires: International Index of Erectile Function (IIEF-5), Pittsburgh Sleep Quality Index (PSQI), Morningness-Eveningness Questionnaire (MEQ), Depression Anxiety Stress Scales-42 (DASS-42), and General Health Questionnaire-28 (GHQ-28). Statistical analyses, including Spearman’s correlation and Kruskal-Wallis tests, evaluated the relationships between sleep quality, chronotype, and ED. The average age was 31.03 ± 8.06 years. Significant correlations were found: Poor sleep quality was linked to lower erectile function (r = −0.379, p < 0.001), while morning chronotype correlated with better erectile function (r = 0.424, p < 0.001). Regression analysis confirmed these as significant predictors of ED (R 2 = 0.200, p < 0.001). Sleep quality and chronotype are crucial factors in ED management, suggesting targeted interventions could be beneficial.
- Open Access
- 7 February 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-7
Prevention of infectious complications after transrectal ultrasound-guided prostate biopsy: comparison of povidone-iodine, chlorhexidine, and formalin disinfection
Purpose: We aimed to compare the efficacy of three different antiseptic methods to determine the most effective prophylactic approach to prevent infectious complications after transrectal ultrasound-guided prostate biopsy (TRUS-PB). The methods evaluated were transrectal povidone-iodine injection (TRPI), biopsy needle disinfection with chlorhexidine, and biopsy needle disinfection with formalin. Methods: Between January 2018 and January 2023, 904 patients who underwent TRUS-PB were retrospectively analyzed. All patients had prophylactic antibiotic use and negative urine/rectal culture results. Patients were divided into three groups according to the antiseptic protocol: Group 1 ( n = 245) received only TRPI injection into the rectum before biopsy, Group 2 ( n = 295) received only chlorhexidine needle disinfection before biopsy, and Group 3 ( n = 364) received only formalin needle disinfection before biopsy. The biopsy needles used in our clinic are not single-use and are used on other patients after sterilization. The primary endpoint was the incidence of infectious complications within 30 days post-procedure. Continuous variables were analyzed using the Mann-Whitney U test, while categorical variables were analyzed using the Chi-square test, and post-hoc analysis was applied for pairwise comparisons between groups. Univariate and multivariate logistic regression analysis was performed to evaluate factors associated with postoperative infection. Results: The overall infection rate was 20.4%. Infection rates were 4.5% in the TRPI group, 16.6% in the chlorhexidine group, and 34.1% in the formalin group ( p < 0.001). The TRPI group showed significantly lower rates of all infectious complications compared to other groups. Disinfection of biopsy needles with chlorhexidine was found to be significantly more effective in preventing infectious complications compared to disinfection with formalin ( p < 0.001). Conclusion: TRPI injection before TRUS-PB appears to be more effective in preventing post-biopsy infectious complications compared to needle disinfection with chlorhexidine or formalin. This method may be considered as a preferred antiseptic approach for TRUS-PB procedures.
- 7 February 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-7
Open AccessPrevention of infectious complications after transrectal ultrasound-guided prostate biopsy: comparison of povidone-iodine, chlorhexidine, and formalin disinfection
Purpose: We aimed to compare the efficacy of three different antiseptic methods to determine the most effective prophylactic approach to prevent infectious complications after transrectal ultrasound-guided prostate biopsy (TRUS-PB). The methods evaluated were transrectal povidone-iodine injection (TRPI), biopsy needle disinfection with chlorhexidine, and biopsy needle disinfection with formalin. Methods: Between January 2018 and January 2023, 904 patients who underwent TRUS-PB were retrospectively analyzed. All patients had prophylactic antibiotic use and negative urine/rectal culture results. Patients were divided into three groups according to the antiseptic protocol: Group 1 ( n = 245) received only TRPI injection into the rectum before biopsy, Group 2 ( n = 295) received only chlorhexidine needle disinfection before biopsy, and Group 3 ( n = 364) received only formalin needle disinfection before biopsy. The biopsy needles used in our clinic are not single-use and are used on other patients after sterilization. The primary endpoint was the incidence of infectious complications within 30 days post-procedure. Continuous variables were analyzed using the Mann-Whitney U test, while categorical variables were analyzed using the Chi-square test, and post-hoc analysis was applied for pairwise comparisons between groups. Univariate and multivariate logistic regression analysis was performed to evaluate factors associated with postoperative infection. Results: The overall infection rate was 20.4%. Infection rates were 4.5% in the TRPI group, 16.6% in the chlorhexidine group, and 34.1% in the formalin group ( p < 0.001). The TRPI group showed significantly lower rates of all infectious complications compared to other groups. Disinfection of biopsy needles with chlorhexidine was found to be significantly more effective in preventing infectious complications compared to disinfection with formalin ( p < 0.001). Conclusion: TRPI injection before TRUS-PB appears to be more effective in preventing post-biopsy infectious complications compared to needle disinfection with chlorhexidine or formalin. This method may be considered as a preferred antiseptic approach for TRUS-PB procedures.